Bloomberg Facilitates Execution & Clearing of CDS & IRS E-Trades
J.P. Morgan executes trades with multiple firms on FIT Platform
Bloomberg prepares for launch of Swap Execution Facility
Bloomberg executives today announced that J.P. Morgan electronically executed and cleared credit default swap (CDS) and interest-rate swap (IRS) trades on Bloomberg's Fixed Income Electronic Trading platform (FIT).
The trades demonstrate that Bloomberg's Fixed Income business is preparing to meet the broadly defined requirements of the Dodd-Frank Act, which calls for increased transparency and market efficiency in over-the-counter (OTC) derivatives trading. Bloomberg intends to register with the U.S. Commodity Futures Trading Commission (CFTC) and the U.S. Securities and Exchange Commission (SEC) as a Swap Execution Facility (SEF) and Security Based Swap Execution Facility (SBSEF), respectively.
Leveraging J.P. Morgan’s function (JPTE <GO>) on the Bloomberg Professional® service, the first CDS single-dealer trading page on the service, the credit indices were executed and submitted to ICE Trust (ICE) for clearing while the IRS trade was executed and submitted to LCH.Clearnet Ltd's SwapClear service (LCH.Clearnet) through the J.P. Morgan (JPSX <GO>) page on the Bloomberg IRS Single-Dealer page (IFIT). Also executed on JPTE were trades intermediated through J.P. Morgan’s Prime Brokerage.
Ben Macdonald, global head of Bloomberg's Fixed Income business, said, “These trades represent the next generation of electronic trading and clearing. Today's execution, our ability to handle large volumes, and our VCON voice affirmation platform, demonstrate Bloomberg’s ability to provide clients with any option they need." Macdonald added, "Having all of your fixed income tools in one single, integrated system is convenient and helps eliminate opportunities for risk."
"We found that Bloomberg’s FIT platform is an excellent way for us to execute and clear credit index trades,” said Rob Milam, co-head of North American Credit Trading at J.P. Morgan. “We've been at the forefront of electronic trading since we first offered CDS single dealer trading via JPTE in 2009.”
Among the clients participating in the trades were: BlueMountain Capital Management, Claren Road Asset Management, Diamond Notch Asset Management, Gracie Credit Opportunities Fund and PAMLI Capital Management LLC.
Greg Pearson, Gracie Credit Opportunities Fund Chief Financial Officer said, "With the changing OTC landscape, easily navigating the new work-flow is of utmost importance to our stakeholders. Gracie Credit is working with Bloomberg and J.P. Morgan because they are market leaders in fixed income electronic trading, which we find to be an important emerging platform for executing our investment strategy."
Earlier this month, Bloomberg's FIT completed more than $1 trillion in electronically traded IRS and CDS for 2011, making it the market leader. Bloomberg clients have leveraged direct connectivity to CME Clearing, ICE, the International Derivatives Clearing Group (IDCG) and LCH.Clearnet for voice-executed transactions since 2009. Also, Bloomberg now has 23 liquidity providers active for IRS trading, and 11 dealers live for CDS trading.
For a demonstration of e-trading of derivatives on FIT, type SEF<GO> on the Bloomberg Professional® service or contact Jeff Missimer at 212-617-2236 or at jmissimer@bloomberg.net ; in Europe or Asia please contact Richard Warrick at +44-20-7330-7604 or at rwarrick@bloomberg.net .
About Bloomberg
Bloomberg is the world’s most trusted source of information for financial professionals and businesses. Bloomberg combines innovative technology with unmatched analytics, data, news, and display and distribution capabilities, to deliver critical information via the Bloomberg Professional® service and multimedia platforms, including Bloomberg Businessweek and Bloomberg Markets magazines. Bloomberg's media properties span television, radio, digital and print, making up one of the world’s largest news organizations. Headquartered in New York, the company employs more than 12,900 people in 166 locations around the world. For more information go to www.bloomberg.com
Contact:
Bloomberg LP
Pam Snook
+212-617-7652
pamsnook@bloomberg.net
or
Cognito
- US
Sophie Fischman
+1-646-395-6300
Bloomberg@cognitomedia.com
or
Stuart
Macaulay – EMEA
+44 20 7438 1100
BloombergEMEA@cognitomedia.com
or
Anne
Karumo - APAC
+65 8112 64 09
BloombergAsia@cognitomedia.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ICD 2025: New data demonstrate Nemluvio®’s (nemolizumab) favorable safety profile and sustained and clinically meaningful improvements in symptoms of prurigo nodularis up to two years18.6.2025 07:00:00 CEST | Press release
An interim analysis of the OLYMPIA long-term extension study to be presented as a late-breaking abstract at the XIV International Congress of Dermatology (ICD) found that Nemluvio was well tolerated and associated with sustained and clinically meaningful improvements in the key signs and symptoms of prurigo nodularis, including both skin lesions and itch, up to two years1 Results build on data from OLYMPIA – the largest completed pivotal clinical program in prurigo nodularis and the only one assessing long-term safety and efficacy in prurigo nodularis1-3 This follows the presentation of data from the ARCADIA long-term extension study at the Revolutionizing Atopic Dermatitis (RAD) Conference earlier this month, which showed Nemluvio is well tolerated with sustained and increased improvements in efficacy outcomes in atopic dermatitis patients up to two years4 Galderma (SIX: GALD) today announced data from a new interim analysis of a study investigating the long-term safety and efficacy o
LabPMM® Receives New York State Approval for the NPM1 MRD Assay - Informing Therapy and Accelerating Targeted Trials18.6.2025 06:30:00 CEST | Press release
Invivoscribe is happy to announce that its wholly owned subsidiary, the Laboratory for Personalized Molecular Medicine® (LabPMM) has received approval from New York State (NYS) for the NPM1 MRD Assay. This approval comes just two months after gaining NYS approval for our FLT3 ITD MRD Assay. Together these tests represent a critical tool for patients with acute myeloid leukemia (AML), clinicians and pharmaceutical companies. This new approval underscores Invivoscribe’s ongoing commitment to providing the most accurate, standardized measurable residual disease (MRD) testing solutions worldwide. The NPM1 MRD Assay is a pivotal development in the fight against AML, offering an ultra-sensitive DNA sequencing method to accurately measure trace levels of residual leukemia cells in patients with the NPM1 mutation variants. NPM1 mutations are considered an ideal target for MRD assessment because they are present in ~30% of adult AML cases,1 stable over time,2 and, if present in blood at allele
DNP to Take Controlling-Stake in Laxton18.6.2025 03:30:00 CEST | Press release
Maximizing synergies to accelerate the global expansion of biometric info-driven government authentication and security business Dai Nippon Printing Co., Ltd. (DNP, TOKYO: 7912) entered into a share transfer agreement on June 17, 2025 to acquire Cayman Islands-headquartered Rubicon SEZC. Rubicon (a holding company of “Laxton” group) is a global Identity Systems Integrator that provides ID solutions for governments, primarily in developing nations, to register and authenticate personal information. DNP plans to acquire 75% of Rubicon's shares in July and complete the procedures to make the company a Group company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250613922077/en/ Products of Laxton DNP will maximize synergies with Laxton in ID cards and card printers. By expanding to government-related business in Africa, Asia, South America, and other regions, we will further grow our authentication and security business, contr
DNP: Operational Launch of 2,500 mm-Width Coating Line to Enhance Production Capacity by 15%18.6.2025 03:20:00 CEST | Press release
- To accommodate large-scale TVs and high-end model demands - Dai Nippon Printing Co., Ltd. (DNP) is pleased to announce the September operational launch of a coating device compatible with 2,500 mm-width high functional optical film at our Mihara Plant in Hiroshima Prefecture. The operational launch of the second wide coating device comes in response to market and consumer needs, and will boost production capacity by more than 15% on an area basis. With the increased capacity, DNP will accommodate the demand for high functional optical film for 65-inch large-screen TVs, with horizontal and vertical dimensions of 1,436.4 mm x 809.0 mm, which are expected to increase at a compound annual growth rate (CAGR) of approximately 6% between 2025 and 20301 on an area basis. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250613720341/en/ Image of Mihara Plant [Features] Facilitates the efficient manufacture, or imposition, of high fun
Alipay Enables In-Store Payment Functionality in China for AR Glasses in Collaboration with Rokid to Build Immersive Commerce18.6.2025 02:27:00 CEST | Press release
Over 250,000 units of Rokid Glasses have already been ordered, integrated with Alipay’s digital payment technology for AR glasses.The integration of payments into AR glasses supports a future of seamless, intuitive commerce—enabling instant, gesture-based transactions, immersive product discovery, and new ways for businesses to engage customers. Rokid, a pioneer in augmented reality (AR), today launched Rokid Glasses, its latest AR device. In China, the product supports in-store payments facilitated by Alipay’s digital payment technology and multidimensional risk control solution for AR glasses, providing a seamless and secure payment experience. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250617845457/en/ Rokid partners with Alipay to launch China’s first AR glasses with in-store payment capabilities. According to Rokid, the product will begin rolling out to users starting in June 2025, with over 250,000 units already or
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom